ABSTRACT:
In comparison to oral NSAIDs, topical nonsteroidal anti-inflammatory drugs (NSAIDs) for osteoarthritis provide at least equivalent analgesia, improve physical function, reduce stiffness, and have fewer systemic adverse events. Topical diclofenac is one such NSAID. Although topical diclofenac has been shown to be successful in treating osteoarthritis, nothing is known about how long the medication takes to start working, how long it lasts, and what the lowest therapeutic concentration is. Localization and medication penetration are two factors that might affect these values. Diclofenac concentrations in the tissues of the joints are probably more important than those in the plasma. Despite the fact that diclofenac enters and remains in these "effect compartments" at the site I.e. The results of our study suggest that topical NSAIDs, like diclofenac, are a generally well-tolerated, safe, and effective first-line treatment option for osteoarthritis (OA) of the knee and hands. This is especially true for older patients, those with comorbid conditions, and those who are at risk for gastrointestinal, hepatic, renal, or cardiovascular systemic adverse events that are linked to oral NSAID use, especially when using high doses over an extended period of time of inflammation and medication action, no particular minimum effective concentration of the drug has been found in either synovial tissue or plasma. Recent data indicates that plasma concentrations may not be the most accurate indicator of effectiveness than a decrease in inflammatory markers. This narrative evaluation examines the data that is currently available in these fields and highlights any gaps that require more investigation.
Cite this article:
Varun Singh, Monika Devi, Kapil Kumar Verma. A Review article on Diclofenac Sodium Topical gel on Osteoarthritis. Research Journal of Topical and Cosmetic Sciences. 2024; 15(1):53-9. doi: 10.52711/2321-5844.2024.00010
Cite(Electronic):
Varun Singh, Monika Devi, Kapil Kumar Verma. A Review article on Diclofenac Sodium Topical gel on Osteoarthritis. Research Journal of Topical and Cosmetic Sciences. 2024; 15(1):53-9. doi: 10.52711/2321-5844.2024.00010 Available on: https://rjtcsonline.com/AbstractView.aspx?PID=2024-15-1-10
REFERENCES:
1. Wolff DG, Christophersen C, Brown SM, Mulcahey MK. Topical nonsteroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a systematic review and meta-analysis. The Physician and Sportsmedicine. 2021 Oct 2; 49(4):381-91.
2. Richard MJ, Driban JB, McAlindon TE. Pharmaceutical treatment of osteoarthritis. Osteoarthritis and Cartilage. 2023 Apr 1; 31(4): 458-66.
3. Gollnick H, Dirschka T, Ostendorf R, Kerl H, Kunstfeld R. Long‐term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials. Journal of the European Academy of Dermatology and Venereology. 2020 Jan; 34(1): 82-9.
4. Herbig ME, Evers DH, Gorissen S, Köllmer M. Rational Design of Topical Semi-Solid Dosage Forms-How Far Are We. Pharmaceutics. 2023 Jun 26; 15(7): 1822.
5. Maulvi FA, Shetty KH, Desai DT, Shah DO, Willcox MD. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration. International journal of pharmaceutics. 2021 Oct 25; 608: 121105.
6. Pagar KR, Khandbahale SV, Kasar PM. Osteoarthritis: Pathophysiology and current treatment modalities. Asian Journal of Pharmaceutical Research. 2019 Oct; 9(4): 289-98.
7. Kraus VB, Sprow K, Powell KE, Buchner D, Bloodgood B, Piercy K, George SM, Kraus WE. Effects of physical activity in knee and hip osteoarthritis: a systematic umbrella review. Medicine and science in sports and exercise. 2019 Jun; 51(6):1324.
8. Haasbroek C. Overweight, obesity and associated risk factors in the South African Air Force, Bloemfontein (Doctoral dissertation, University of the Free State).
9. Xie Z, Wang L, Chen J, Zheng Z, Srinual S, Guo A, Sun R, Hu M. Reduction of Systemic Exposure and Side Effects by Intra-articular Injection of Anti-inflammatory Agent for Osteoarthritis: What is the Safer Strategy. Journal of Drug Targeting. 2023 May 30(just-accepted): 1-30.
10. Drumond N, Stegemann S. Better medicines for older patients: Considerations between patient characteristics and solid oral dosage form designs to improve swallowing experience. Pharmaceutics. 2020 Dec 28; 13(1): 32.
11. Wang TF, Grubic N, Carrier M, Canney M, Delluc A, Hundemer GL, Knoll G, Lazo‐Langner A, Massicotte‐Azarniouch D, Tanuseputro P, Sood MM. Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty. American Journal of Hematology. 2023 Jun 21.
12. Kotowska-Rodziewicz A, Zalewska A, Maciejczyk M. A Review of Preclinical and Clinical Studies in Support of the Role of Non-Steroidal Anti-Inflammatory Drugs in Dentistry. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2023; 29: e940635-1.
13. Bookman AA, Williams KS, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ 2004; 171: 3338
14. Honvo G, Leclercq V, Geerinck A, Thomas T, Veronese N, Charles A, Rabenda V, Beaudart C, Cooper C, Reginster JY, Bruyère O. Safety of topical non-steroidal anti-inflammatory drugs in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs and aging. 2019 Apr 1; 36: 45-64.
15. Baraf HS, Gold MS, Clark MB, Altman RD. Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial. The Physician and Sportsmedicine. 2010 Jun 1; 38(2): 19-28.
16. da Costa BR, Pereira TV, Saadat P, Rudnicki M, Iskander SM, Bodmer NS, Bobos P, Gao L, Kiyomoto HD, Montezuma T, Almeida MO. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ. 2021 Oct 12; 375.
17. Revel FB, Fayet M, Hagen M. Topical diclofenac, an efficacious treatment for osteoarthritis: a narrative review. Rheumatology and Therapy. 2020 Jun 1; 7(2): 217-36.
18. Bijlsma JWJ. Strategies for the prevention and management of osteoarthritis of the hip and knee. Best Pract Res Clin Rheumatol 2007; 21: 59e76.
19. Qing Yu Zeng, Ren Chen, John Yu Xiao et al. Rheumatic diseases in China. Arthritis Res Ther 2008; 10: R17.
20. Kalichman L, Ling L, Kobyliansky E. Prevalence, pattern and determinants of radiographic hand osteoarthritis in Turkmen community-based sample. Rheumatol Int. 2009; 29: 1143–49
21. Fransen M, Bridgett L, March L et al. The epidemiology of osteoarthritis in Asia. Int J Rheum Dis. 2011; 14:113–21.
22. Jordan JM, Helmick CG, Renner JB et al. Prevalence of hip symptoms and radiographic and symptomatic hip osteoarthritis in African-Americans and Caucasians: The Johnston County Osteoarthritis Project. J Rheumatol. 2009; 36: 809–15.
23. Ali M, Batt M. An update on the pathophysiology of osteoarthritis. Ann Phys Rehabil Med. 2016; 333–9. https://doi.org/10.1016/j.rehab.2016.07.004
24. Loeser Richard F. Aging and osteoarthritis. Curr Opin Rheumatol. 2011; 492–6. https://doi.org/10.1097/BOR.0b013e3283494005.
25. Frey MI, Barrett-Conner E, Sledge PA et al. The effect of noninsulin dependent diabetes on the prevalence of clinical osteoarthritis. A population-based study. J Rheumatol. 1996; 23: 716–22.
26. Puenpatom RA, Victor TW. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med. 2009; 121: 9–20.
27. Arden NK, Lane NE, Parimi N et al. Defining incident radiographic hip osteoarthritis for epidemiologic studies in women. Arthritis Rheum. 2009;60:
28. de Klerk BM, Schiphof D, Groeneveld FP et al. No clear association between female hormonal aspects and osteoarthritis of the hand, hip and knee: a systematic review. Rheumatology (Oxford). 2009; 48:1160–5.
29. Michelle Hui, Michael Doherty, Weiya Zhang. Does smoking protect against osteoarthritis Meta-analysis of observational studies. Ann Rheum Dis. 2011; 70:1231–7.
30. Blagojevic M, Jinks C, Jeffery A et al. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage. 2010; 18:24–33.
31. Hadler NM, Gillings DB, Imbus HR et al. Hand structure and function in an industrial setting. Arthritis Rheum 1978; 21:210–20
32. Spector TD, Harris PA, Hart DJ et al. Risk of osteoarthritis associated with long-term weight bearing sports: a radiologic survey of the hips and knees in female ex-athletes and population controls. Arthritis Rheum. 1996; 39:988–95.
33. Tanamas S, Hann FS, Cicuttini FM et al. Does knee malalignment increase the risk of development and progression of knee osteoarthritis? A systematic review. Arthritis Rheum. 2009; 61:459–67.